Owner only: item control page
Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: results of the prospective randomized RIST trial
Corbacioglu, Selim
(2023)
Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: results of the prospective randomized RIST trial.
In: ASCO annual meeting, 2.-6.6.2023, Chicago.
(Unpublished)
Date of publication of this fulltext: 20 Mar 2023 10:09
Conference or workshop item
DOI to cite this document: 10.5283/epub.53968
Involved Institutions
Details
| Item type | Conference or workshop item (UNSPECIFIED) |
| Open Access Type: | No Open Access |
|---|---|
| Place of Publication: | Chicago |
| Date | 2023 |
| Institutions | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation |
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine |
| Status | Unpublished |
| Refereed | Unknown |
| Created at the University of Regensburg | Yes |
| URN of the UB Regensburg | urn:nbn:de:bvb:355-epub-539684 |
| Item ID | 53968 |
Export bibliographical data
Owner only: item control page
Download Statistics
Download Statistics